Ihuman Inc Stock Today

IH Stock  USD 1.67  0.02  1.21%   

Performance

1 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Less than 19

 
High
 
Low
Low
Ihuman is trading at 1.67 as of the 3rd of December 2024. This is a 1.21 percent increase since the beginning of the trading day. The stock's open price was 1.65. Ihuman has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Ihuman Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Business Domain
Consumer Services
IPO Date
9th of October 2020
Category
Consumer Defensive
Classification
Consumer Discretionary
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the Peoples Republic of China. The company was founded in 1996 and is based in Beijing, the Peoples Republic of China. Ihuman Inc operates under Education Training Services classification in the United States and is traded on New York Stock Exchange. The company has 23.57 M outstanding shares of which 6.13 K shares are currently sold short in the market by investors with about 0.29 days to cover all shorted shares. More on Ihuman Inc

Moving together with Ihuman Stock

  0.79YQ 17 Education TechnologyPairCorr

Moving against Ihuman Stock

  0.42UTI Universal TechnicalPairCorr
  0.39LOPE Grand Canyon EducationPairCorr
  0.35EEIQ Elite Education GroupPairCorr
  0.35LINC Lincoln EducationalPairCorr
  0.34LRN Stride IncPairCorr

Ihuman Stock Highlights

CEOPeng Dai
Thematic Ideas
Showing 3 out of 4 themes
Business ConcentrationHotels, Restaurants & Leisure, Education & Training Services, Consumer Discretionary, NYSE Composite, Railroads, Books, Personal Services, Education, Consumer Discretionary, Hotels, Restaurants & Leisure, Education & Training Services, Consumer Defensive (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover1.170.7019
Way Up
Slightly volatile
Gross Profit Margin0.520.7084
Way Down
Slightly volatile
Total Current Liabilities410.5 M490.8 M
Fairly Down
Slightly volatile
Total Assets945.7 M1.5 B
Way Down
Slightly volatile
Total Current Assets897.1 M1.4 B
Way Down
Slightly volatile
Debt Levels
Ihuman can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ihuman's financial leverage. It provides some insight into what part of Ihuman's total assets is financed by creditors.
Liquidity
Ihuman Inc reports 3.86 M of total liabilities with total debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from financial leverage. Ihuman Inc has a current ratio of 2.22, indicating that it is in good position to pay out its debt commitments in time. Note however, debt could still be an excellent tool for Ihuman to invest in growth at high rates of return.

Change In Cash

222.37 Million
Ihuman Inc (IH) is traded on New York Stock Exchange in USA. It is located in Building B, Beijing, China, 100102 and employs 783 people. Ihuman is listed under Hotels, Restaurants & Leisure category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a market capitalization of 85.89 M. Ihuman Inc is active under Hotels, Restaurants & Leisure sector as part of Consumer Discretionary industry. The entity has 23.57 M outstanding shares of which 6.13 K shares are currently sold short in the market by investors with about 0.29 days to cover all shorted shares. Ihuman Inc reports about 1.05 B in cash with 172.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Ihuman Probability Of Bankruptcy
Ownership Allocation
Ihuman Inc has a total of 23.57 Million outstanding shares. Roughly 99.39 (percent) of Ihuman outstanding shares are held by general public with 0.61 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ihuman Ownership Details

Ihuman Stock Institutional Holders

InstituionRecorded OnShares
Arisaig Partners (asia) Pte Ltd2024-06-30
1.2 M
Citadel Advisors Llc2024-09-30
38.4 K
Morgan Stanley - Brokerage Accounts2024-09-30
19.9 K
Rhumbline Advisers2024-09-30
11.4 K
Two Sigma Securities, Llc2024-09-30
11.2 K
Crédit Agricole S.a.2024-09-30
10 K
Ubs Group Ag2024-09-30
4.5 K
State Street Corp2024-09-30
0.0
Susquehanna International Group, Llp2024-06-30
0.0
Qube Research & Technologies2024-09-30
0.0
Xtx Topco Ltd2024-09-30
0.0
View Ihuman Diagnostics

Ihuman Historical Income Statement

As of now, Ihuman's Net Income From Continuing Ops is increasing as compared to previous years. The Ihuman's current EBIT is estimated to increase to about 167.9 M, while Depreciation And Amortization is projected to decrease to under 6 M. View More Fundamentals

Ihuman Stock Against Markets

Ihuman Corporate Management

Wendy HayesIndependent DirectorProfile
Yufeng ChiChairman of the BoardProfile
Xuenan LiIndependent DirectorProfile
Hanfeng ChiDirectorProfile
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ihuman Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Earnings Share
(0.16)
Revenue Per Share
18.263
Quarterly Revenue Growth
(0.11)
Return On Assets
0.0456
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.